about
A prospective randomized controlled trial of AJG522 versus standard PEG+E as bowel preparation for colonoscopy.Favorable outcome of retreatment by direct-acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failureAnalyses of objective response rate, progression-free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective studySuccessful prolonged treatment of glecaprevir/pibrentasvir for chronic hepatitis C patient with treatment failure after 8-week therapy: a case report
P50
description
investigador
@es
researcher
@en
name
Ken Sato
@en
type
label
Ken Sato
@en
prefLabel
Ken Sato
@en
P31
P496
0000-0002-3202-7983